Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH36523FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Exelixis Inc (EXEL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company’s marketed products include: Cometriq (cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (cabozantinib) developed for the treatment of patients with advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). The company’s pipeline product candidates include XL092 for the treatment of advanced solid malignancies and XL888, an ATP-competitive inhibitor of HSP90, and others. The company has collaborative partnerships with biopharmaceutical companies to advance the development of potential therapies for cancer and other serious diseases. Exelixis is headquartered in Alameda, California, the US.

Exelixis Inc Key Recent Developments

Feb 19,2021: Exelixis to Webcast Virtual Fireside Chat as Part of the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021
Feb 10,2021: Exelixis announces fourth quarter and full year 2020 financial results and provides corporate update
Jan 10,2021: Exelixis announces preliminary fourth quarter and full year 2020 financial results, provides 2021 financial guidance, and outlines key priorities and anticipated milestones for 2021
Nov 05,2020: Exelixis announces third quarter 2020 financial results and provides corporate update
Aug 06,2020: Exelixis announces second quarter 2020 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Exelixis Inc – Key Facts
Exelixis Inc – Key Employees
Exelixis Inc – Key Employee Biographies
Exelixis Inc – Major Products and Services
Exelixis Inc – History
Exelixis Inc – Company Statement
Exelixis Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Exelixis Inc – Business Description
Product Category: Collaboration Revenues
Overview
Performance
Product Category: Net Product Revenues
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: United States
Performance
Exelixis Inc – Corporate Strategy
Exelixis Inc – SWOT Analysis
SWOT Analysis – Overview
Exelixis Inc – Strengths
Exelixis Inc – Weaknesses
Exelixis Inc – Opportunities
Exelixis Inc – Threats
Exelixis Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Exelixis Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 19, 2021: Exelixis to Webcast Virtual Fireside Chat as Part of the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021
Feb 10, 2021: Exelixis announces fourth quarter and full year 2020 financial results and provides corporate update
Jan 10, 2021: Exelixis announces preliminary fourth quarter and full year 2020 financial results, provides 2021 financial guidance, and outlines key priorities and anticipated milestones for 2021
Nov 05, 2020: Exelixis announces third quarter 2020 financial results and provides corporate update
Aug 06, 2020: Exelixis announces second quarter 2020 financial results and provides corporate update
May 05, 2020: Exelixis announces first quarter 2020 financial results and provides corporate update
Apr 21, 2020: Exelixis to Release First Quarter 2020 Financial Results on Tuesday, May 5, 2020
Mar 03, 2020: Exelixis announces George A. Scangos, Ph.D. to retire from its Board of Directors
Feb 25, 2020: Exelixis announces fourth quarter and full year 2019 financial results and provides corporate …
Jan 12, 2020: Exelixis outlines key priorities and anticipated milestones for 2020-21, announces preliminary fourth quarter and full year 2019 financial results, and provides 2020 financial guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Exelixis Inc, Key Facts
Exelixis Inc, Key Employees
Exelixis Inc, Key Employee Biographies
Exelixis Inc, Major Products and Services
Exelixis Inc, History
Exelixis Inc, Subsidiaries
Exelixis Inc, Key Competitors
Exelixis Inc, Ratios based on current share price
Exelixis Inc, Annual Ratios
Exelixis Inc, Annual Ratios (Cont...1)
Exelixis Inc, Annual Ratios (Cont...2)
Exelixis Inc, Interim Ratios
Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Exelixis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Exelixis Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Exelixis Inc (EXEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Taiwan Financial Holding Co Ltd:企業の戦略・SWOT・財務分析
    Taiwan Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taiwan Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Oglethorpe Power Corporation:電力:M&Aディール及び事業提携情報
    Summary Oglethorpe Power Corporation (Oglethorpe) is a member-owned non-profit electric utility that provides wholesale electric power to retail electric distribution cooperative members. The cooperative operates through a diverse portfolio of owned and leased power supply resources utilizing natura …
  • Heidelberg Pharma AG (WL6):企業の財務・戦略的SWOT分析
    Heidelberg Pharma AG (WL6) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • International Business Machines Corp (IBM):企業の財務・戦略的SWOT分析
    International Business Machines Corp (IBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Dover Corp (DOV):企業の財務・戦略的SWOT分析
    Dover Corp (DOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Momenta Pharmaceuticals Inc (MNTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s products include Glatopa; and Enoxaparin Sodium Injection. Its pipeline portfolio encompasses candidates to su …
  • Hindustan Tin Works Limited:企業の戦略・SWOT・財務情報
    Hindustan Tin Works Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Tin Works Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Itamar Medical Ltd (ITMR):医療機器:M&Aディール及び事業提携情報
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, markets and sells diagnostic medical devices for the diagnosis and treatment of sleep apnea. The company’s products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction assessment tool fo …
  • Hecla Mining Company:企業の戦略・SWOT・財務分析
    Hecla Mining Company - Strategy, SWOT and Corporate Finance Report Summary Hecla Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Magellan Aerospace Corp:企業の戦略・SWOT・財務情報
    Magellan Aerospace Corp - Strategy, SWOT and Corporate Finance Report Summary Magellan Aerospace Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Asia Paper Manufacturing Co., Ltd.:企業の戦略・SWOT・財務情報
    Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Asia Paper Manufacturing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CP All Public Company Ltd (CPALL):企業の財務・戦略的SWOT分析
    CP All Public Company Ltd (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CoImmune Inc (ARGS):企業の財務・戦略的SWOT分析
    Summary CoImmune Inc(CoImmune) formerly known as Argos Therapeutics Inc, is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platfo …
  • Visterra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases. The company develops precision antibody-based biological medicines for infectious and non-infectious diseases. I …
  • GP Batteries International Ltd:企業の戦略的SWOT分析
    GP Batteries International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Calamos Asset Management, Inc.:企業の戦略・SWOT・財務分析
    Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Calamos Asset Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pinar Entegre Et ve Un Sanayi AS:企業の戦略・SWOT・財務情報
    Pinar Entegre Et ve Un Sanayi AS - Strategy, SWOT and Corporate Finance Report Summary Pinar Entegre Et ve Un Sanayi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆